Gastro-intestinal Cancer Gene Panel

What is Gastro-Intestinal Cancer Gene Panel test?

A Gastro-Intestinal (GI) Cancer Gene Panel is a next-generation sequencing (NGS) test that assesses multiple genes associated with hereditary GI cancers to identify actionable mutations for diagnosis, risk assessment, targeted therapy, and clinical trial eligibility. It can be ordered as a germline panel for inherited cancer risk for therapeutic biomarkers in cancers such as colorectal, gastric, pancreatic, hepatobiliary, and GIST.

Why consider Gastro-Intestinal Cancer Gene Panel test?

• When a patient has symptoms or imaging suggesting GI cancers (like colorectal, gastric, pancreatic cancers), the gene panel can help identify specific genetic mutations linked to the tumor.
• Identifying mutations helps doctors choose targeted therapies or immunotherapies that are more effective for the patient’s tumor type.
• The panel can identify germline mutations that may affect family members and require genetic counselling.
• Monitor Treatment Response and Resistance

Who should get tested for Gastro-Intestinal Cancer Gene Panel test?

• Patients with advanced or metastatic GI cancers where tumor profiling may reveal biomarkers for targeted therapy or immunotherapy
• Patients with Strong Family History of GI Cancers
• Patients Being Considered for ImmunotherapyMore Information

More information about Gastro-Intestinal Cancer Gene Panel test

OTHER NAMES: Hereditary GI Cancer Panel; GI Hereditary Cancer Gene Panel, GI Tumor Profiling Panel; GI Comprehensive Genomic Profiling; GI NGS Panel

A Gastro-Intestinal (GI) Cancer refers to cancers that develop in the digestive system, including the esophagus, stomach, liver, pancreas, small intestine, large intestine, rectum, and anus. Symptoms can include unexplained weight loss, abdominal pain, changes in bowel habits, nausea, vomiting, and jaundice, though early stages may show no symptoms